Symposia & Breakouts

20 November 2024, 15:05 CET, 9:05 ET

Cryoablation and PFA: Competing or Complementary in AF Management?

This symposium is supported by Medtronic

 

Chair

Faizel Osman, Coventry, UK

Panel

Neil Srinivasan, Basildon, UK; Verena Tscholl, Berlin, DE and Ioanna Koniari, Liverpool, UK

Agenda
  • The Ice Age: Exploring the Future of Cryoballoon Ablation – Dr Neil Srinivasan

  • Energising Ablation: Unlocking the Power of Pulsed Field Technology – Dr Verena Tscholl

  • Synergy in Practice: Enhancing Outcomes with Cryoballoon and Pulsed Field Ablation – Dr Ioanna Koniari

Learning Objectives

  • Examine the roles of cryoablation and pulsed field ablation (PFA) in AF management, understanding where each energy source fits within current clinical practices
  • Evaluate the evidence, advantages and potential limitations of cryoballoon and PFA technologies in AF ablation
  • Assess the real-world evidence for combined use of cryoablation and PFA in clinical practice, focusing on how these techniques may complement each other to improve patient outcomes

 

20 November 2024, 17:00 CET, 11:00 ET

AF Care Pathway in 2025: From Ablation to Stroke Prevention

This symposium is supported by Boston Scientific

 

Chairs

Christian-Hendrik Heeger, Hamburg, DE and Sandrine Venier, Grenoble, FR

Panel

Reza Wakili, Frankfurt DE, Gábor Széplaki, Dublin, IE and Lucas Boersma, Nieuwegein, NL

Agenda
  • Introduction
  • Ablation as First Line, Treatment of Persistent AF Strategy, Concomitant Ablation/LAAC – Prof Reza Wakili
  • Integrated Mapping for PFA - Initial Experience – Prof Gábor Széplaki
  • OPTION Trial Results – Prof Lucas Boersma
  • Discussion and Q&A

Learning Objectives

  • Discuss the care pathway for AF patients in light of most recent AF management guidelines
  • Discuss ablation strategies for Persistent AF
  • Show latest technologies of integrated mapping with Pulsed field Ablation
  • Share the results of OPTION trial
  • Share expert opinion on concomitant Ablation and LAAC

20 November 2024, 21:00 CET, 15:00 ET

4D ICE Guided Concomitant PFA and LAAC: Optimal Outcomes with AcuNav Lumos

This symposium is supported by Siemens Healthineers

 

Chair

Devi Nair, Jonesboro, US

Panel

Amin Al-Ahmad, Austin, US; Kevin Makati, Tampa, US; Robert Percell, Lincoln, US and Walid Saliba, Cleveland, US

 

Why 4D ICE

Recognize how AcuNav Lumos 4D ICE can help drive procedural efficiency to monitor for complications during a concomitant procedure with superior imaging of cardiovascular structure and anatomy, deploy therapy and ensure tissue contact for PFA, with the use of a single 4D ICE catheter.

Agenda
  • Welcome Remarks and Panel Introductions – Dr Devi Nair

  • Introduction to 4D ICE Imaging and AcuNav Lumos – Dr Kevin Makati

  • Case Presentation Part 1 - Transeptal Puncture, PVI and PFA Contact Guided by 4D ICE – Dr Devi Nair

  • Pros and Cons of a Concomitant Procedure – Dr Walid Saliba

  • Case Presentation Part 2 – PFA, CT Measurements, Sheath Exchange – Dr Devi Nair

  • 4D ICE Views for LAAC – Dr Amin Al-Ahmad

  • Case Presentation Part 3 – LAAC – Dr Devi Nair

  • Panel Discussion – All

Learning Objectives

  • Workflow: Understand the workflow advantages of AcuNav Lumos 4D ICE over traditional imaging techniques in the assessment and guidance of a concomitant procedure for pulse field ablation and LAA closure

  • Patient Benefits: Discuss the clinical benefits of using AcuNav Lumos 4D ICE for the patient, including improved visualization of cardiac structures and enhanced procedural efficiency.

  • Why 4D ICE: Recognize how AcuNav Lumos 4D ICE can help drive procedural efficiency to monitor for complications during a concomitant procedure

 

Date Thursday 21 2024, 16:00 CET, 10:00 ET

PFA - An Integrated Approach

This symposium is supported by Johnson & Johnson MedTech

 

Chair

Devi Nair, Jonesboro, US

Panel

Dinesh Sharma, Naples, US; David DeLurgio, Atlanta, US; Moussa Mansour, Boston US

Learning Objectives

  • See benefits of using pulsed field ablation technology in an AF ablation procedure.
  • Understand the value of integrating mapping and ablation to provide optimal therapy.

22 November 2024, 15:05 CET, 09:05 ET

Modular ICD Therapy, a Paradigmatic Change in SCD Prevention

This symposium is supported by Boston Scientific

 

Chair

Lluis Mont, Barcelona, ES

Panel

Clemens Steinwender, Linz, AT and John Paisey, Southampton, UK

Agenda
  • Introduction – Prof Lluis Mont
  • Introduction to Modular ICD Therapy: A New Era in Personalised Cardiac Care – Prof Clemens Steinwender
  • Modular CRM, Introducing an Upgrade Care Pathway Focusing on Patient Selection – Dr John Paisey
  • Discussion and Q&A

Learning Objectives

  • Understand the concept of modular Cardiac Rhythm Management (mCRM)
  • Evaluate the shifts in SCD prevention approaches and explain the upgrade pathway in modular CRM
  • Discuss patient-centric benefits and limitations around modular
  • Identify patient selection criteria for modular CRM
  • Analyse the Benefits of a personalised cardiac care approach
  • Identify key clinical indicators for personalised ICD selection

23 November 2024, 15:05 CET, 9:05 ET

The Next Era in Cardiac Ablation: Simplified and Adaptable Workflows Across Complex Ablation Cases With Multiple PFA Systems

This symposium is supported by Medtronic

 

Chair

Devi Nair, Arkansas, US

Panel

Andrea Sarkozy, Brussels, BE and Erich Kiehl, Newport News, US

Agenda
  • A Streamlined Single Catheter Workflow With AfferaTM Sphere-9TM Catheter – Dr Erich Kiehl
  • Real World Affera Mapping and Ablation System Use in Complex Cases – Prof Andrea Sarkozy
  • The Durability Zero Fluoro Workflow With PulseSelectTM PFA System – Dr Devi Nair
  • Discussion and Q&A

Learning Objectives

  • Review a live case outlining an over the wire PFA Loop Catheter and LAAO Concomitant procedure
  • Discuss complex case experience to date including the use of AfferaTM Mapping & Ablation System for a complex atrial tachycardia
  • Demonstrate a short learning curve and seamless workflow with a single catheter to map, ablate and validate
  • Discover PFA durability study data and a zero-fluoro workflow with PulseSelectTM PFA system

23 November 2024, 13:10 ET, 19:10 CET

Optimizing the Future of Complex AF Ablation with AI

This symposium is supported by Volta Medical and GE HealthCare

 

Chair

Paul Zei, Boston, US

Panel

Stavros Mountantonakis, New York, US; Devi Nair, Jonesboro, US

Agenda

  • Welcome and Introduction to the Technology - Dr Paul Zei 

  • AI in EP and an Overview of Voltaplex - Dr Paul Zei 

  • De Novo Persistent AF Case With Volta AF-Xplorer and GE Cardiolab - Dr Stavros Mountantonakis 

  • Case Presentation PFA +Volta and Summary of APHRS Abstract - Dr Devi Nair 

  • Panel Discussion and Q&A – All 

  • Closing Remarks - Dr Paul Zei

Learning Objectives

  • Learn more about artificial intelligence in electrophysiology, specifically Volta Medical’s data collection and annotation ecosystem
  • Gain insights into how to utilize GE CardioLab for optimal signal clarity and Volta Medical’s AF-Xplorer in complex AF cases
  • See the advantages of combining AF-Xplorer with Pulsed Field Ablation (PFA) for treating complex AF patients, drawing from cases and recent research findings

Headline Partners

Partners

Supporting Partners

Join the Conversation
#RIOcongress2024

Official Journal

Arrhythmia and Electrophysiology Review (AER) is an international, English language, peer-reviewed journal that is published quarterly and aims to assist time-pressured physicians to stay abreast of key advances and opinion in the area of arrhythmia and cardiac electrophysiology.

The journal comprises balanced and comprehensive review articles written by leading authorities. The journal provides updates on a range of salient issues to support physicians in developing their knowledge and effectiveness in day-to-day clinical practice.

The journal endeavours to support the continuous medical education of specialist and general cardiologists and disseminate knowledge of the field to the wider cardiovascular community.

Led by Editor-in-Chief, Prof Demosthenes Katrisis along with Section Editors and an editorial board of world-renowned physicians, the Journal publishes peer-reviewed articles that aim to provide timely updates on the most pertinent issues in the field.

View the latest volume of AER.

About Radcliffe Cardiology

We are Radcliffe, a knowledge network for the cardiovascular community

We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.

We bring medical knowledge to life

From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.

Our work is underpinned by 3 core principles:

  • We build on the best science
  • We work hands-on with our community
  • We bring fresh thinking


Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.

For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com.